Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors ; volume:51 ; number:4 ; year:2018 ; pages:1982-1995
Cellular physiology and biochemistry ; 51, Heft 4 (2018), 1982-1995
- Urheber
-
Kaneko, Yuji
Tuazon, Julian P.
Ji, Xunming
Borlongan, Cesario V.
- DOI
-
10.1159/000495722
- URN
-
urn:nbn:de:101:1-2018121923275771312448
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kaneko, Yuji
- Tuazon, Julian P.
- Ji, Xunming
- Borlongan, Cesario V.
Ähnliche Objekte (12)
Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation
Pituitary adenylate cyclase-activating polypeptide expression in peripheral blood mononuclear cells of migraineurs
Zur neuroprotektiven Wirkung des „Pituitary Adenylate Cyclase-Activating Polypeptide" gegenüber toxischen Alzheimer-Amyloid-Peptiden
Charakterisierung eines spezifischen Membranrezeptors für das regulatorische Peptid "Pituitary Adenylate Cyclase Activating Polypeptide" (PACAP)
Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
The Effects of Pituitary Adenylate Cyclase Activating Polypeptide in Renal Ischemia/Reperfusion : A Review
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptan
Age-related alterations of articular cartilage in pituitary adenylate cyclase–activating polypeptide (PACAP) gene–deficient mice
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells
Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
Untersuchung der Struktur-Funktions-Beziehung des Pituitary Adenylate Cyclase Activating Polypeptide Response Gene 1 (PRG1-IEX-1)
Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation
Pituitary adenylate cyclase-activating polypeptide expression in peripheral blood mononuclear cells of migraineurs
Zur neuroprotektiven Wirkung des „Pituitary Adenylate Cyclase-Activating Polypeptide" gegenüber toxischen Alzheimer-Amyloid-Peptiden
Charakterisierung eines spezifischen Membranrezeptors für das regulatorische Peptid "Pituitary Adenylate Cyclase Activating Polypeptide" (PACAP)
Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
The Effects of Pituitary Adenylate Cyclase Activating Polypeptide in Renal Ischemia/Reperfusion : A Review
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptan
Age-related alterations of articular cartilage in pituitary adenylate cyclase–activating polypeptide (PACAP) gene–deficient mice
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells
Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
Untersuchung der Struktur-Funktions-Beziehung des Pituitary Adenylate Cyclase Activating Polypeptide Response Gene 1 (PRG1-IEX-1)
Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation
Pituitary adenylate cyclase-activating polypeptide expression in peripheral blood mononuclear cells of migraineurs
Zur neuroprotektiven Wirkung des „Pituitary Adenylate Cyclase-Activating Polypeptide" gegenüber toxischen Alzheimer-Amyloid-Peptiden
Charakterisierung eines spezifischen Membranrezeptors für das regulatorische Peptid "Pituitary Adenylate Cyclase Activating Polypeptide" (PACAP)
Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
The Effects of Pituitary Adenylate Cyclase Activating Polypeptide in Renal Ischemia/Reperfusion : A Review
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptan
Age-related alterations of articular cartilage in pituitary adenylate cyclase–activating polypeptide (PACAP) gene–deficient mice
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells
Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine